Repeat epilepsy surgery may help many children with TSC

Repeat epilepsy surgery may help many children with TSC
Credibility
Interest
Share:2 min read
Key Takeaway

Single or repeat epilepsy surgery helped many children with tuberous sclerosis have fewer or no seizures, and earlier surgery often worked better.

What They Found

Researchers looked back at 62 children with tuberous sclerosis who had 120 epilepsy surgeries to see how well surgery controlled seizures over time. About half had one surgery and half had more than one, and the types of surgery were similar between the groups. When surgery targeted a known problem spot in the brain, about 76% of single-surgery patients and 66% of patients with two or more surgeries had that spot stop causing seizures. Overall (looking at all possible seizure sources), 69% of single-surgery patients and 55% of repeat-surgery patients became seizure-free. Some people still became seizure-free after a third or fourth surgery, and about 29% of recurring seizures came from new brain areas that only showed up after the first surgery.

Who Should Care and Why

Patients and families living with tuberous sclerosis and epilepsy should care because surgery can meaningfully reduce or stop seizures, which can improve daily life and learning. Caregivers may see benefits like fewer seizure-related interruptions, improved school performance, and better overall mood and energy for the child. Neurologists and epilepsy surgeons should note that repeat surgeries can help when seizures return or when new seizure areas appear, so one surgery does not mean there are no more options. The finding that earlier surgery was linked to better results suggests discussing surgery sooner (when appropriate) could improve chances of becoming seizure-free. Think of it like fixing potholes on a busy road: fixing the biggest pothole first often helps traffic, but sometimes new potholes appear later and need another repair to keep the road smooth.

Important Considerations

This study looked back at medical records, which can miss some details and can’t prove cause and effect like a planned trial can. Results come from two major hospitals and may not be exactly the same everywhere, so talk with your care team about how it fits your situation. Also, while many did well after repeat surgeries, outcomes varied and not everyone became seizure-free, so realistic expectations and close follow-up are important.

AI-generated summary — for informational purposes only, not medical advice

Article Topics:
epilepsy surgeryepileptogenic networksrefractory epilepsyrepeat surgeries

You May Also Like

Gut Bacteria and MS: What You Need to Know
Gut Bacteria and MS: What You Need to Know

12/31/2026

Learn how certain gut bacteria can worsen MS symptoms and what this means for treatment and daily li

Read More
Clear gut bacteria clues for MS — what it means today
Clear gut bacteria clues for MS — what it means today

12/31/2026

Researchers found consistent gut bacteria differences in MS tied to disease type, treatment response

Read More
How the Brain Saves Energy: Possible Clues for MS Care
How the Brain Saves Energy: Possible Clues for MS Care

10/1/2026

Study finds different brain cells use unique ways to survive low-energy states; this could inspire f

Read More
Rare nerve-only autoimmune signs tied to Ma/Ma2 cancer
Rare nerve-only autoimmune signs tied to Ma/Ma2 cancer

9/1/2026

A small study found Ma/Ma2 antibodies can cause nerve-only symptoms often linked to cancer; testing

Read More
Ravulizumab cuts relapses in AQP4+ NMO long-term for patients
Ravulizumab cuts relapses in AQP4+ NMO long-term for patients

9/1/2026

Long-term study shows ravulizumab greatly reduced relapses in AQP4+ NMOSD over 3+ years with expecte

Read More
Double-Negative NMOSD: Risks and Early Treatment Now
Double-Negative NMOSD: Risks and Early Treatment Now

9/1/2026

Even without common antibodies, NMOSD can be severe and relapsing; early maintenance immune treatmen

Read More
Understanding MS Research

Whether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Epilepsia often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.

However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.

By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.